NeuMoDx SARS-CoV-2 Assay -IVD intended for the qualitative detection of SARS-CoV-2 RNA from nasa...
FDA Recall #Z-2093-2023 — Class III — May 15, 2023
Product Description
NeuMoDx SARS-CoV-2 Assay -IVD intended for the qualitative detection of SARS-CoV-2 RNA from nasal, nasopharyngeal and oropharyngeal swabs in transport medium and bronchoalveolar lavage (BAL) specimens from individuals suspected of COVID-19 by their healthcare provider (HCP). REF Number: 300800
Reason for Recall
Potential for lot number discrepancies between the test strip packaging and the barcode label applied to the test strip that is read by the instrument for LOT 123909 of NeuMoDx SARS-CoV-2 Test Strips (REF 300800). The instrument registers the non-human readable text as lot number 123910 from the barcode label.
Recalling Firm
NeuMoDx Molecular Inc — Ann Arbor, MI
Classification
Class III — Not likely to cause adverse health consequences.
Product Type
Devices
Product Quantity
1,086 test strips
Distribution
US Nationwide distribution in the states of FL, MI, NM, NY, TN, TX.
Code Information
GTIN: 10814278021264 Lot Number: 123909 Exp. Date: 08-Dec-2023
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated
What Should You Do?
Stop using this medical device immediately and consult your healthcare provider. Contact the recalling firm for instructions on return or replacement. If you experienced an adverse event, inform your doctor.